天美生物(BON)

1.36+0.62+84.86%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
天美生物
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.bnlus.com;en.appchem.cn
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
天美生物有限公司根据开曼群岛法律于2019年12月11日注册成立。西安天美生物科技股份有限公司创立于2006年，是国内从事植物提取物研发、生产和销售的现代生物科技型企业，致力于为功能性食品、个人护理等领域提供植物活性成分及复方产品解决方案。2021年6月，西安天美生物在美国纳斯达克证券交易所挂牌上市，股票代码BON。公司总部位于陕西省西安市高新区，设有独立研发中心及检测实验室，拥有渭南、铜川两个生产基地，新增在建甘肃玉门生产基地，营销网络覆盖国内外。天美生物先后获得食品生产许可证、食品经营许可证、知识产权管理体系认证、ISO9001质量管理体系认证、ISO22000食品安全管理体系认证、美国FDA检查认证、Kosher、Halal等多项认证，在生物制造领域，天美生物各环节均符合国家各项相关标准及要求。
- 03-13 12:00
  [修订]招股说明书
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
- 03-03
  [修订]招股说明书
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
- 02-19
  [修订]招股说明书
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
- 01-28
  年度报告
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 01-17
  [修订]招股说明书
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
- 2024-11-19
  招股说明书
  Form F-1 - Registration statement for certain foreign private issuers
  Form F-1 - Registration statement for certain foreign private issuers
- 2024-10-11
  [修订]年度报告
  Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
  Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
- 2024-10-11
  [修订]年度报告
  Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
  Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
- 2024-02-09
  年度报告
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2023-05-15
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2023-05-15
  [修订]年度报告
  Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
  Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
- 2023-02-10
  年度报告
  20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2022-12-27
  员工持股计划
  S-8 - Securities to be offered to employees in employee benefit plans
  S-8 - Securities to be offered to employees in employee benefit plans
- 2022-12-02
  SEC问询函
  CORRESP [Cover] - Correspondence
  CORRESP [Cover] - Correspondence
- 2022-11-22
  SEC问询函
  CORRESP [Cover] - Correspondence
  CORRESP [Cover] - Correspondence

分时
5日
日
周
月

数据加载中...

最高

2.95

今开

1.61

量比

19.57

最低

1.14

昨收

0.7357

换手率

3805.92%

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

天美生物(BON)

公司概况

热议股票